Lyon, France

Lionel Chalus

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp.. Active years: 2004-2013.

USPTO Granted Patents = 4 

% Patents Active = 25.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004-2013

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Lionel Chalus

Introduction

Lionel Chalus is a notable inventor based in Lyons, France. He has made significant contributions to the field of biotechnology, particularly in the area of monocyte-derived nucleic acids. With a total of 4 patents to his name, Chalus has demonstrated a commitment to advancing scientific knowledge and applications.

Latest Patents

Chalus's latest patents focus on monocyte-derived nucleic acids and related compositions and methods. These patents describe nucleic acids encoding various monocyte-derived proteins, including purified proteins and specific antibodies. Additionally, methods of using such compositions are provided, showcasing the practical applications of his innovations.

Career Highlights

Throughout his career, Lionel Chalus has worked with prominent companies in the pharmaceutical industry, including Schering Corporation and Merck Sharp & Dohme Corp. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical science.

Collaborations

Chalus has collaborated with esteemed colleagues such as Elizabeth Bates and Nathalie Fournier. These partnerships have likely enriched his research and development efforts, fostering an environment of innovation and creativity.

Conclusion

Lionel Chalus is a distinguished inventor whose work in monocyte-derived nucleic acids has the potential to impact the field of biotechnology significantly. His patents and collaborations reflect a dedication to scientific advancement and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…